THDB(SH:600867) Zheng Quan Zhi Xing·2025-06-20 12:02Core Viewpoint - The controlling shareholder, Dongbao Industrial Group Co., Ltd., has increased its stake in Tonghua Dongbao Pharmaceutical Co., Ltd. from 31.06% to 32.07%, indicating confidence in the company's future development and value recognition [4][8]. Summary by Relevant Sections Shareholding Changes - The total shareholding percentage before the change was 31.06%, and after the change, it is 32.07% [1][8]. - The increase in shareholding was achieved through a series of transactions, including a planned increase of at least 1% of the total share capital, which equates to 19,817,341 shares, and a maximum of 2%, or 39,634,681 shares, within a 12-month period starting from October 31, 2024 [4][5]. Transaction Details - From October 31, 2024, to November 15, 2024, Dongbao Group acquired 2,050,100 shares for a total amount of 17,773,752.93 yuan, representing 0.1034% of the company's total share capital [5]. - From November 16, 2024, to January 2, 2025, Dongbao Group further acquired 5,968,600 shares, increasing its shareholding percentage to 31.37% [6][8]. Share Buyback Program - The company completed its second phase of share buyback, repurchasing 23,191,245 shares, which accounted for 1.17% of the total share capital, with an average buyback price of 7.76 yuan per share [7][8]. - The buyback led to a passive increase in the shareholding percentage of Dongbao Group and its concerted actors, from 31.37% to 31.74% [8]. Regulatory Compliance - The changes in shareholding do not trigger mandatory tender offer obligations and will not result in changes to the company's controlling shareholder or actual controller [8].